Barclays
DRRX

Barclays’s DURECT Corp DRRX Stock Holding History

Barclays’s Portfolio DRRX Stock Details DRRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,200
Closed -$19K – 5151
2023
Q4 		$19K Buy
+32,200
New +$45.9K ﹤0.01% 4911

Other funds holding DRRX

ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
MAM
Montchanin Asset Management Montchanin, Delaware $98.1M AUM
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Barclays's DRRX Position: Q1 2024 in Review

Barclays sold out of DURECT Corp (DRRX) in Q1 2024, closing a stake of 5,000 shares — an estimated $2.95K sold.

Barclays first reported a position in DRRX in Q1 2014 and held it in 36 quarters. The position peaked at $369K in Q1 2021. 41 funds tracked by Wall St. Rank hold DRRX as of Q1 2024.

  • Barclays reported no remaining DURECT Corp position as of Q1 2024 after selling out during the quarter.
  • Barclays sold 5,000 DURECT Corp shares in Q1 2024, an estimated $2.95K.
  • Barclays first reported a position in DURECT Corp in Q1 2014 and held it in 36 quarters.
  • Barclays's DURECT Corp position peaked at $369K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held DURECT Corp as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.